Anavex Life Sciences Ownership | Who Owns Anavex Life Sciences?

Overview ForecastFinancials Chart Transcripts

Anavex Life Sciences Ownership Summary

Anavex Life Sciences is owned by 34.72% institutional investors, 3.06% insiders, and 62.22% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 7.85% of AVXL shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.98% of its assets in Anavex Life Sciences shares.

AVXL Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Anavex Life Sciences	34.72%	3.06%	62.22%
Sector	Healthcare Stocks	57.39%	9.93%	32.68%
Industry	Biotech Stocks	68.48%	9.65%	21.87%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Blackrock funding, inc. /de	6.55M	7.85%	$70.37M
Blackrock	6.39M	7.75%	$26.97M
Vanguard group	4.68M	5.61%	$50.27M
State street	2.41M	2.84%	$25.90M
Geode capital management	1.87M	2.25%	$20.14M
Susquehanna group, llp	1.13M	1.36%	$12.19M
Nwam	913.05K	1.09%	$9.81M
Two sigma investments, lp	776.90K	0.93%	$8.34M
Northern trust	669.16K	0.81%	$2.82M
Charles schwab investment management	677.22K	0.81%	$7.27M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Pier capital	441.92K	0.68%	$4.75M
Nwam	913.05K	0.61%	$9.81M
Allsquare wealth management	51.97K	0.32%	$558.12K
Saxon interests	25.69K	0.12%	$275.88K
Prairiewood capital	20.80K	0.10%	$223.39K
Heartland advisors	155.85K	0.09%	$1.67M
Hikari power	85.58K	0.08%	$919.00K
Watts gwilliam	26.00K	0.07%	$349.96K
Scientech research	19.14K	0.06%	$205.61K
Sculptor capital lp	370.10K	0.05%	$3.97M

Top Buyers

Holder	Shares	% Assets	Change
Susquehanna group, llp	1.13M	0.00%	896.32K
Invesco	615.05K	0.00%	590.64K
Pier capital	441.92K	0.68%	441.92K
Essential planning, llc.	413.09K	0.02%	413.09K
Ubs group	418.76K	0.00%	288.71K

Top Sellers

Holder	Shares	% Assets	Change
Wealthgarden f.s.	-	-	-910.48K
Jupiter asset management	-	-	-804.64K
State street	2.41M	0.00%	-654.02K
Bank of america corp /de/	175.90K	0.00%	-388.80K
Blackrock	6.39M	0.00%	-254.07K

New Positions

Holder	Shares	% Assets	Change	Value
Pier capital	441.92K	0.68%	441.92K	$4.75M
Essential planning, llc.	413.09K	0.02%	413.09K	$3.25M
Wellington management group llp	158.67K	0.00%	158.67K	$1.70M
Heartland advisors	155.85K	0.09%	155.85K	$1.67M
Jump financial	153.23K	0.03%	153.23K	$1.65M

Sold Out

Holder	Change
Nelson, van denburg & campbell wealth management group	-14.00
Russell investments group	-115.00
Capital performance advisors llp	-135.00
Bangor savings bank	-150.00
Colonial trust advisors	-200.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2024	180	17.65%	29,442,084	5.60%	34	3.11%	98	38.03%	38	22.58%
Sep 30, 2024	151	1.34%	27,864,882	4.09%	32	3.13%	72	16.13%	30	-33.33%
Jun 30, 2024	148	-6.33%	26,770,748	-15.94%	32	2.16%	62	-17.33%	44	-
Mar 31, 2024	158	-5.39%	31,845,742	23.59%	38	3.94%	75	-11.76%	44	15.79%
Dec 31, 2023	167	9.87%	25,766,532	3.24%	31	3.30%	85	19.72%	38	-15.56%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard US Total Market Shares ETF	2.53M	2.98%	-
Vanguard Total Stock Mkt Idx Inv	2.53M	2.98%	-
iShares Russell 2000 ETF	1.98M	2.33%	-17.21K
SPDR® S&P Biotech ETF	1.56M	1.84%	-16.74K
Vanguard Institutional Extnd Mkt Idx Tr	1.32M	1.55%	33.85K
Fidelity Small Cap Index	750.11K	0.88%	-14.05K
iShares Biotechnology ETF	526.79K	0.62%	-5.87K
iShares Russell 2000 Value ETF	506.43K	0.60%	-
Fidelity Extended Market Index	462.50K	0.54%	536.00
State St Russell Sm/Mid Cp® Indx NL Cl C	413.80K	0.49%	-19.40K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Jun 14, 2024	Donhauser Peter D.O.	-	Buy	$10.32K
May 15, 2024	Thomas Steffen	-	Buy	$22.60K
Mar 28, 2024	MISSLING CHRISTOPHER U	President and CEO	Sell	$374.97K
Jun 28, 2023	MISSLING CHRISTOPHER U	President and CEO	Sell	$2.14M
May 25, 2022	Skarpelos Athanasios		Sell	$453.00K

Insider Transactions Trends

Date	Buy	Sell
2024 Q2	1	-
2024 Q1	-	1
2023 Q2	-	1
2023 Q1	-	-
2022 Q2	-	1

AVXL Ownership FAQ

Who Owns Anavex Life Sciences?

Anavex Life Sciences shareholders are primarily institutional investors at 34.72%, followed by 3.06% insiders and 62.22% retail investors. The average institutional ownership in Anavex Life Sciences's industry, Biotech Stocks , is 68.48%, which Anavex Life Sciences falls below.

Who owns the most shares of Anavex Life Sciences?

Anavex Life Sciences’s largest shareholders are Blackrock funding, inc. /de (6.55M shares, 7.85%), Blackrock (6.39M shares, 7.75%), and Vanguard group (4.68M shares, 5.61%). Together, they hold 21.21% of Anavex Life Sciences’s total shares outstanding.

Does Blackrock own Anavex Life Sciences?

Yes, BlackRock owns 7.75% of Anavex Life Sciences, totaling 6.39M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 26.97M$. In the last quarter, BlackRock decreased its holdings by -254K shares, a -3.82% change.

Who is Anavex Life Sciences’s biggest shareholder by percentage of total assets invested?

Pier capital is Anavex Life Sciences’s biggest shareholder by percentage of total assets invested, with 0.68% of its assets in 441.92K Anavex Life Sciences shares, valued at 4.75M$.

Who is the top mutual fund holder of Anavex Life Sciences shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Anavex Life Sciences shares, with 2.98% of its total shares outstanding invested in 2.53M Anavex Life Sciences shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools